BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,573,000 | -13.1% | 71,879 | -3.8% | 0.05% | -7.5% |
| Q4 2021 | $6,410,000 | +3.7% | 74,682 | -2.8% | 0.05% | -8.6% |
| Q3 2021 | $6,179,000 | -2.9% | 76,820 | -2.8% | 0.06% | -3.3% |
| Q2 2021 | $6,363,000 | -20.4% | 79,045 | -16.6% | 0.06% | +3.4% |
| Q1 2021 | $7,993,000 | -6.5% | 94,767 | -11.0% | 0.06% | -1.7% |
| Q4 2020 | $8,547,000 | -11.9% | 106,514 | -11.7% | 0.06% | -10.6% |
| Q3 2020 | $9,700,000 | -21.0% | 120,615 | -15.5% | 0.07% | -32.7% |
| Q2 2020 | $12,286,000 | +60.5% | 142,693 | +51.3% | 0.10% | +38.0% |
| Q1 2020 | $7,656,000 | -6.6% | 94,293 | -3.8% | 0.07% | +26.8% |
| Q4 2019 | $8,195,000 | -16.8% | 97,997 | -12.9% | 0.06% | -6.7% |
| Q3 2019 | $9,845,000 | +7.3% | 112,558 | +0.5% | 0.06% | -4.8% |
| Q2 2019 | $9,174,000 | -30.5% | 112,014 | -31.0% | 0.06% | -34.4% |
| Q1 2019 | $13,205,000 | +0.2% | 162,403 | -18.9% | 0.10% | -10.3% |
| Q4 2018 | $13,180,000 | -47.8% | 200,240 | -41.4% | 0.11% | -38.9% |
| Q2 2018 | $25,230,000 | +8.5% | 341,692 | -4.4% | 0.18% | +20.7% |
| Q1 2018 | $23,258,000 | – | 357,595 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |